PriceTargets.com logo

Jamieson Wellness - JWEL Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: C$36.69
  • Forecasted Upside: 2.99%
  • Number of Analysts: 4
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
C$35.63 As of 11/20/2024 01:00 AM ET
▲ +0.38 (1.08%)

This chart shows the closing price for JWEL by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Jamieson Wellness Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for JWEL and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for JWEL

Analyst Price Target is C$36.69
▲ +2.99% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for Jamieson Wellness in the last 3 months. The average price target is C$36.69, with a high forecast of C$42.00 and a low forecast of C$27.00. The average price target represents a 2.99% upside from the last price of C$35.63.

This chart shows the closing price for JWEL for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 4 polled investment analysts is to moderate buy stock in Jamieson Wellness. This rating has held steady since August 2023, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 1 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
5/30/2023
  • 1 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
8/28/2023
  • 1 strong buy ratings
  • 4 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
11/26/2023
  • 1 strong buy ratings
  • 5 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
2/24/2024
  • 0 strong buy ratings
  • 6 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
5/24/2024
  • 0 strong buy ratings
  • 5 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
8/22/2024
  • 0 strong buy ratings
  • 4 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
10/21/2024
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
11/20/2024

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
11/8/2024Royal Bank of CanadaBoost TargetC$37.00 ➝ C$38.00
11/8/2024TD SecuritiesBoost TargetBuyC$40.00 ➝ C$42.00
8/9/2024BMO Capital MarketsBoost TargetC$35.00 ➝ C$42.00
8/9/2024Canaccord Genuity GroupBoost TargetC$32.50 ➝ C$36.25
8/9/2024Royal Bank of CanadaBoost TargetC$32.00 ➝ C$37.00
8/9/2024TD SecuritiesBoost TargetC$36.00 ➝ C$40.00
7/18/2024TD SecuritiesBoost TargetBuyC$32.00 ➝ C$36.00
5/10/2024CIBCLower TargetC$28.00 ➝ C$27.00
5/10/2024Royal Bank of CanadaBoost TargetC$31.00 ➝ C$32.00
5/10/2024TD SecuritiesLower TargetC$39.00 ➝ C$32.00
3/15/2024CIBCLower TargetC$32.00 ➝ C$28.00
3/14/2024Royal Bank of CanadaLower TargetOutperformC$35.00 ➝ C$31.00
3/14/2024BMO Capital MarketsLower TargetC$40.00 ➝ C$35.00
3/14/2024Eight CapitalLower TargetC$46.00 ➝ C$38.00
3/14/2024National BanksharesLower TargetC$38.50 ➝ C$36.00
3/14/2024ScotiabankLower TargetC$32.00 ➝ C$29.00
3/14/2024Stifel NicolausLower TargetC$45.00 ➝ C$42.00
3/14/2024TD SecuritiesDowngradeAction List Buy ➝ BuyC$42.00 ➝ C$39.00
2/28/2024CIBCBoost TargetNeutralC$27.00 ➝ C$32.00
1/8/2024National BanksharesLower TargetOutperformC$43.50 ➝ C$38.50
11/28/2023Stifel NicolausSet TargetC$45.00
11/3/2023ScotiabankLower TargetSector PerformC$35.00 ➝ C$32.00
11/3/2023BMO Capital MarketsLower TargetOutperformC$42.00 ➝ C$40.00
11/3/2023Royal Bank of CanadaLower TargetOutperformC$38.00 ➝ C$35.00
11/3/2023TD SecuritiesLower TargetAction List BuyC$50.00 ➝ C$42.00
9/21/2023Stifel NicolausLower TargetBuyC$50.00 ➝ C$45.00
8/8/2023CIBCLower TargetNeutralC$37.00 ➝ C$32.00
8/4/2023Royal Bank of CanadaLower TargetOutperformC$42.00 ➝ C$38.00
7/25/2023Canaccord Genuity GroupLower TargetBuyC$42.00 ➝ C$41.25
5/5/2023Royal Bank of CanadaBoost TargetOutperformC$41.00 ➝ C$42.00
5/5/2023ScotiabankBoost TargetC$38.50 ➝ C$39.00
2/27/2023Canaccord Genuity GroupLower TargetC$45.00 ➝ C$42.00
2/27/2023CIBCLower TargetNeutralC$41.00 ➝ C$37.00
2/24/2023Royal Bank of CanadaLower TargetOutperformC$42.00 ➝ C$41.00
2/24/2023ScotiabankLower TargetC$39.00 ➝ C$38.50
11/7/2022Canaccord Genuity GroupLower TargetC$46.00 ➝ C$45.00
11/7/2022CIBCLower TargetOutperformC$46.00 ➝ C$41.00
11/4/2022Royal Bank of CanadaLower TargetOutperformC$45.00 ➝ C$42.00
8/29/2022TD SecuritiesUpgradeBuy ➝ Action List BuyC$50.00
8/5/2022Royal Bank of CanadaLower TargetOutperformC$46.00 ➝ C$45.00
6/3/2022Royal Bank of CanadaBoost TargetOutperformC$39.00 ➝ C$46.00
6/2/2022National BanksharesBoost TargetOutperformC$42.75 ➝ C$46.25
6/2/2022TD SecuritiesBoost TargetBuyC$45.00 ➝ C$50.00
6/2/2022CIBCBoost TargetOutperformC$42.00 ➝ C$45.00
6/2/2022ScotiabankBoost TargetC$37.00 ➝ C$39.00
6/2/2022Eight CapitalBoost TargetNAC$44.00 ➝ C$46.00
5/9/2022BMO Capital MarketsUpgradeMarket Perform ➝ BuyC$37.00 ➝ C$42.00
2/25/2022Royal Bank of CanadaLower TargetOutperformC$43.00 ➝ C$39.00
2/25/2022CIBCLower TargetOutperformC$44.00 ➝ C$42.00
1/21/2022TD SecuritiesUpgradeHold ➝ BuyC$40.00 ➝ C$45.00
11/8/2021CIBCBoost TargetOutperformC$40.00 ➝ C$44.00
11/5/2021TD SecuritiesBoost TargetHoldC$38.00 ➝ C$40.00
11/5/2021ScotiabankBoost TargetC$40.00 ➝ C$41.00
11/2/2021Canadian Imperial Bank of CommerceReiterated RatingOutperformC$40.00
8/6/2021CIBCLower TargetC$45.00 ➝ C$40.00
8/3/2021CIBCReiterated RatingOutperformC$45.00
7/30/2021TD SecuritiesReiterated RatingHoldC$38.00
6/9/2021BMO Capital MarketsDowngradeOutperform ➝ Market PerformC$42.00 ➝ C$37.00
5/6/2021Royal Bank of CanadaBoost TargetOutperformC$42.00 ➝ C$43.00
5/3/2021CIBCReiterated RatingOutperformC$45.00
4/19/2021CIBCReiterated RatingOutperformC$45.00
3/23/2021ScotiabankDowngradeOutperform ➝ Sector PerformC$40.00
2/26/2021Royal Bank of CanadaLower TargetOutperformC$44.00 ➝ C$42.00
2/26/2021Eight CapitalLower TargetC$44.00 ➝ C$42.00
2/26/2021CIBCLower TargetC$46.00 ➝ C$45.00
2/26/2021ScotiabankLower TargetC$42.00 ➝ C$40.00
11/12/2020National Bank FinancialBoost TargetOutperformC$41.50 ➝ C$42.75
11/9/2020CIBCBoost TargetC$42.00 ➝ C$46.00
11/6/2020National Bank FinancialBoost TargetOutperformC$41.50 ➝ C$42.75
11/6/2020BMO Capital MarketsBoost TargetC$43.00 ➝ C$45.00
11/6/2020ScotiabankBoost TargetC$37.00 ➝ C$42.00
9/30/2020National Bank FinancialBoost TargetOutperformC$39.75 ➝ C$41.50
9/24/2020National Bank FinancialBoost TargetOutperformC$39.75 ➝ C$41.50
9/18/2020Eight CapitalBoost TargetC$41.00 ➝ C$44.00
8/17/2020CIBCBoost TargetC$36.00 ➝ C$42.00
8/17/2020National Bank FinancialBoost TargetOutperformC$37.50 ➝ C$39.75
8/10/2020National Bank FinancialBoost TargetOutperformC$35.50 ➝ C$39.50
5/17/2020National Bank FinancialBoost TargetOutperformC$33.25 ➝ C$35.50
5/7/2020CIBCSet TargetC$36.00
4/21/2020National Bank FinancialBoost TargetOutperformC$29.75 ➝ C$33.25
4/14/2020BMO Capital MarketsBoost TargetC$30.00 ➝ C$34.00
4/13/2020CIBCBoost TargetC$30.00 ➝ C$33.00
2/21/2020National Bank FinancialBoost TargetOutperformC$29.25 ➝ C$29.75
2/3/2020National Bank FinancialBoost TargetOutperformC$26.50 ➝ C$29.25
12/17/2019Eight CapitalSet TargetBuyC$30.00
12/5/2019BMO Capital MarketsBoost TargetC$25.00 ➝ C$30.00
(Data available from 11/21/2019 forward)

News Sentiment Rating

1.12 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 2 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/25/2024
  • 6 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/25/2024
  • 3 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/24/2024
  • 3 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/24/2024
  • 4 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/23/2024
  • 5 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/22/2024
  • 4 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/22/2024
  • 5 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/21/2024

Current Sentiment

  • 5 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Jamieson Wellness logo
Jamieson Wellness Inc., together with its subsidiaries, develops, manufactures, distributes, markets, and sells of branded and customer branded health products for humans in Canada, the United States, China and internationally. It operates through two segments, Jamieson Brands and Strategic Partners. The Jamieson Brands segment manufactures, distributes, and markets branded natural health products including vitamins, minerals, and supplements. The Strategic Partners segment provides contract manufacturing services to consumer health companies and retailers. The company offers health and wellness supplements under the Jamieson brand; health, beauty, and wellness supplements under the Youtheory brand; and foundational formulas, including probiotics, multivitamins, fish oils, vitamin D, and solution-focused products for better sleep or digestion under the Progressive brand. It also provides plant-based products under the Iron Vegan brand; natural health products for health concerns among women, including hormone imbalances, nutrient deficiencies, and sleep and stress management, and others under the Smart Solutions brand; and sports nutrition supplements under the Precision brand. The company offers its contract manufacturing services under the Nurticorp brand. It sells its products to distributors, and retail and wholesale customers. The company was formerly known as Jamieson Intermediate Holdings Ltd. and changed its name to Jamieson Wellness Inc. in May 2017. Jamieson Wellness Inc. was founded in 1922 and is headquartered in Toronto, Canada.
Read More

Today's Range

Now: C$35.63
Low: C$34.98
High: C$35.69

50 Day Range

MA: C$34.55
Low: C$32.56
High: C$36.48

52 Week Range

Now: C$35.63
Low: C$23.98
High: C$36.77

Volume

25,388 shs

Average Volume

60,874 shs

Market Capitalization

C$1.48 billion

P/E Ratio

41.43

Dividend Yield

2.38%

Beta

0.63

Frequently Asked Questions

What sell-side analysts currently cover shares of Jamieson Wellness?

The following Wall Street analysts have issued stock ratings on Jamieson Wellness in the last year: BMO Capital Markets, Canaccord Genuity Group Inc., CIBC, Eight Capital, National Bankshares, Inc., Royal Bank of Canada, Scotiabank, Stifel Nicolaus, and TD Securities.
View the latest analyst ratings for JWEL.

What is the current price target for Jamieson Wellness?

0 Wall Street analysts have set twelve-month price targets for Jamieson Wellness in the last year. Their average twelve-month price target is C$36.69, suggesting a possible upside of 3.0%. BMO Capital Markets has the highest price target set, predicting JWEL will reach C$42.00 in the next twelve months. CIBC has the lowest price target set, forecasting a price of C$27.00 for Jamieson Wellness in the next year.
View the latest price targets for JWEL.

What is the current consensus analyst rating for Jamieson Wellness?

Jamieson Wellness currently has 1 hold rating and 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for JWEL.

What other companies compete with Jamieson Wellness?

Other companies that are similar to Jamieson Wellness include TriSummit Utilities Inc. (ACI.TO), Tecsys, Real Matters, Avesoro Resources and Else Nutrition. Learn More about companies similar to Jamieson Wellness.

How do I contact Jamieson Wellness' investor relations team?

Jamieson Wellness' physical mailing address is 2 St. Clair Avenue West, TORONTO, ON M4V 1L5, Canada. The company's listed phone number is +1-416-9600052. The official website for Jamieson Wellness is investors.jamiesonwellness.com. Learn More about contacing Jamieson Wellness investor relations.